全文获取类型
收费全文 | 2824篇 |
免费 | 235篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 111篇 |
妇产科学 | 29篇 |
基础医学 | 382篇 |
口腔科学 | 60篇 |
临床医学 | 385篇 |
内科学 | 695篇 |
皮肤病学 | 41篇 |
神经病学 | 183篇 |
特种医学 | 285篇 |
外科学 | 229篇 |
综合类 | 95篇 |
一般理论 | 5篇 |
预防医学 | 176篇 |
眼科学 | 20篇 |
药学 | 187篇 |
中国医学 | 5篇 |
肿瘤学 | 170篇 |
出版年
2023年 | 15篇 |
2022年 | 13篇 |
2021年 | 45篇 |
2020年 | 30篇 |
2019年 | 42篇 |
2018年 | 63篇 |
2017年 | 41篇 |
2016年 | 40篇 |
2015年 | 38篇 |
2014年 | 68篇 |
2013年 | 85篇 |
2012年 | 95篇 |
2011年 | 122篇 |
2010年 | 70篇 |
2009年 | 106篇 |
2008年 | 117篇 |
2007年 | 103篇 |
2006年 | 95篇 |
2005年 | 77篇 |
2004年 | 72篇 |
2003年 | 79篇 |
2002年 | 67篇 |
2001年 | 66篇 |
2000年 | 57篇 |
1999年 | 61篇 |
1998年 | 67篇 |
1997年 | 78篇 |
1996年 | 86篇 |
1995年 | 70篇 |
1994年 | 60篇 |
1993年 | 64篇 |
1992年 | 81篇 |
1991年 | 71篇 |
1990年 | 82篇 |
1989年 | 78篇 |
1988年 | 77篇 |
1987年 | 83篇 |
1986年 | 80篇 |
1985年 | 63篇 |
1984年 | 39篇 |
1983年 | 30篇 |
1982年 | 35篇 |
1981年 | 27篇 |
1980年 | 20篇 |
1979年 | 20篇 |
1978年 | 23篇 |
1977年 | 22篇 |
1976年 | 20篇 |
1975年 | 21篇 |
1974年 | 14篇 |
排序方式: 共有3069条查询结果,搜索用时 0 毫秒
121.
Unger JM Thompson IM LeBlanc M Crowley JJ Goodman PJ Ford LG Coltman CA 《Cancer》2005,103(7):1375-1380
BACKGROUND: The potential public health impact of the recently completed Prostate Cancer Prevention Trial (PCPT) is debated. The results indicated that the period prevalence of prostate cancer was reduced by 24.8% due to finasteride, whereas an increase in the rate of high-grade tumors (Gleason score 8-10) among men who were diagnosed with cancer also was found (5.0% in the PCPT placebo arm vs. 11.9% in the PCPT finasteride arm). Whether the increased Gleason score was valid or was a histologic artifact is under investigation. METHODS: The authors estimated the number of person-years saved assuming a 24.8% reduction in the incidence of prostate cancer for 5 years among United States males age > or = 55 years. Scenarios for different proportions of patients with high-grade Gleason scores also were considered. RESULTS: With a 24.8% reduction in the number of men with newly diagnosed prostate cancer, the authors estimated that 316,760 person-years would be saved due to finasteride in the United States. An absolute increase of 6.9% in the proportion of men with high-grade tumors in the United States cancer population (corresponding to the difference between the rates on the placebo and finasteride arms of the PCPT) would reduce the number of person-years saved to 262,567. For each absolute increase of 5% in the proportion of patients with high-grade tumors, the number of person-years saved would be reduced by approximately 39,000. CONCLUSIONS: The results of the PCPT may have a major impact on population mortality from prostate cancer if they are applied clinically. The potential detrimental effects of an increased rate of patients who have prostate cancer with high-grade Gleason scores would be outweighed by a reduction in incidence. 相似文献
122.
Markaverich BM Crowley JR Alejandro MA Shoulars K Casajuna N Mani S Reyna A Sharp J 《Environmental health perspectives》2005,113(12):1698-1704
Previous studies in our laboratory demonstrated that high-performance liquid chromatography (HPLC) analysis of ground corncob bedding extracts characterized two components (peak I and peak II) that disrupted endocrine function in male and female rats and stimulated breast and prostate cancer cell proliferation in vitro and in vivo. The active substances in peak I were identified as an isomeric mixture of 9,12-oxy-10,13-dihydroxyoctadecanoic acid and 10,13-oxy-9,12-dihydroxyoctadecanoic acid, collectively designated tetrahydrofurandiols (THF-diols). Studies presented here describe the purification and identification of the HPLC peak II component as 9,10-dihydroxy-12-octadecenoic acid (leukotoxin diol; LTX-diol), a well-known leukotoxin. A synthetic mixture of LTX-diol and 12,13-dihydroxy-9-octadecenoic acid (iso-leukotoxin diol; i-LTX-diol) isomers was separated by HPLC, and each isomer stimulated (p < 0.001) MCF-7 cell proliferation in an equivalent fashion. The LTX-diol isomers failed to compete for [3H]estradiol binding to the estrogen receptor or nuclear type II sites, even though oral administration of very low doses of these compounds (> 0.8 mg/kg body weight/day) disrupted estrous cyclicity in female rats. The LTX-diols did not disrupt male sexual behavior, suggesting that sex differences exist in response to these endocrine-disruptive agents. 相似文献
123.
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower 总被引:11,自引:0,他引:11
Thompson IM Ankerst DP Chi C Lucia MS Goodman PJ Crowley JJ Parnes HL Coltman CA 《JAMA》2005,294(1):66-70
Context Three fourths of US men older than 50 years have been screened with prostate-specific antigen (PSA) for prostate cancer. Objective To estimate the receiver operating characteristic (ROC) curve for PSA. Design, Setting, and Participants Calculation of PSA ROC curves in the placebo group of the Prostate Cancer Prevention Trial, a randomized, prospective study conducted from 1993 to 2003 at 221 US centers. Participants were 18 882 healthy men aged 55 years or older without prostate cancer and with PSA levels less than or equal to 3.0 ng/mL and normal digital rectal examination results, followed up for 7 years with annual PSA measurement and digital rectal examination. If PSA level exceeded 4.0 ng/mL or rectal examination result was abnormal, a prostate biopsy was recommended. After 7 years of study participation, an end-of-study prostate biopsy was recommended in all cancer-free men. Main Outcome Measures Operating characteristics of PSA for prostate cancer detection, including sensitivity, specificity, and ROC curve. Results Of 8575 men in the placebo group with at least 1 PSA measurement and digital rectal examination in the same year, 5587 (65.2%) had had at least 1 biopsy; of these, 1225 (21.9%) were diagnosed with prostate cancer. Of 1213 cancers with Gleason grade recorded, 250 (20.6%) were Gleason grade 7 or greater and 57 (4.7%) were Gleason grade 8 or greater. The areas under the ROC curve (AUC) for PSA to discriminate any prostate cancer vs no cancer, Gleason grade 7 or greater cancer vs no or lower-grade cancer, and Gleason grade 8 or greater cancer vs no or lower-grade cancer were 0.678 (95% confidence interval [CI], 0.666-0.689), 0.782 (95% CI, 0.748-0.816), and 0.827 (95% CI, 0.761-0.893), respectively (all P values <.001 for AUC vs 50%). For detecting any prostate cancer, PSA cutoff values of 1.1, 2.1, 3.1, and 4.1 ng/mL yielded sensitivities of 83.4%, 52.6%, 32.2%, and 20.5%, and specificities of 38.9%, 72.5%, 86.7%, and 93.8%, respectively. Age-stratified analyses showed slightly better performance of PSA in men younger than 70 years vs those 70 years or older with AUC values of 0.699 (SD, 0.013) vs 0.663 (SD, 0.013) (P = .03). Conclusion There is no cutpoint of PSA with simultaneous high sensitivity and high specificity for monitoring healthy men for prostate cancer, but rather a continuum of prostate cancer risk at all values of PSA. 相似文献
124.
125.
126.
127.
128.
Nuala Crowley 《Journal of clinical pathology》1970,23(2):166-171
This is a retrospective study of the results of 4,642 blood cultures taken from 2,190 patients from 1960 to 1967 in one London hospital. The results suggested that an increased incidence of bacteraemias at this particular hospital was mainly due to the increase in the number of patients having blood cultures. Some of the bacteraemias were terminal or transient and probably of doubtful clinical significance. 相似文献
129.
130.